Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Surgical Oncology|August 28, 2016
Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgeryA E Slagter, D Ryder, B Chakrabarty, et al.
Medical Oncology (Northwood, London, England)|September 8, 2019
Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancyA R Lewis, C Cipriano, X Wang, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 15, 2016
Sorafenib for the Treatment of Advanced Hepatocellular Cancer - a UK AuditJ King, D H Palmer, P Johnson, et al.
ESMO Open|February 13, 2026
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trialT Macarulla, R Pazo Cid, M S Womack, et al.
ESMO Open|August 5, 2025
Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trialD Melisi, T Macarulla, C De La Fouchardière, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Pageof 2